Inventiva stock has recently seen no change in its fair value target, which remains steady at $7.95 per share. However, updated market narratives highlight a slight increase in the discount rate and ...

Viking Therapeutics Inc. (NASDAQ: VKTX) stock is soaring after the company delivered its third-quarter earnings report. The ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data on Vanoglipel (DA-1241), a ...

An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

Akero Therapeutics (($AKRO)) announced an update on their ongoing clinical study. Study Overview: Akero Therapeutics is conducting a Phase 3 study ...

GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has announced a new clinical study titled ‘A ...

POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for ...

GLP-1 drugs like Mounjaro, which were created to help type 2 diabetes patients and sometimes manage weight loss, actually ...

The campaign encourages early detection and inspires the adoption of a healthy lifestyle to prevent liver cancer ...

The following gastroenterologists lead departments at hospitals ranked in the top 10 for gastroenterology and GI surgery by U.S. News & World Report for 2025-26, following a previous look at the ...

Roche has already signed several high-ticket deals this year, including the $3.5 billion acquisition of 89bio and Genentech’s ...